Literature DB >> 21996165

The accessibility, acceptability, health impact and cost implications of primary healthcare outlets that target injecting drug users: a narrative synthesis of literature.

M Mofizul Islam1, Libby Topp, Carolyn A Day, Angela Dawson, Katherine M Conigrave.   

Abstract

BACKGROUND: Injecting drug users (IDUs) are at increased risk of health problems ranging from injecting-related injuries to blood borne viral infections. Access to primary healthcare (PHC) is often limited for this marginalised group. Many seek care at emergency departments and some require hospital admission due to late presentation. The costs to both the individual and the health system are such that policymakers in some settings have implemented IDU-targeted PHC centres, with a number of models employed. However, there is insufficient evidence on the effectiveness of these centres to inform health service planning. A systematic review examining such interventions is not possible due to the heterogeneous nature of study designs. Nevertheless, an integrative literature review of IDU-targeted PHC may provide useful insights into the range of operational models and strategies to enhance the accessibility and acceptability of these services to the target population.
METHODS: Available literature describing the impact of IDU-targeted PHC on health outcomes, cost implications and operational challenges is reviewed. A narrative synthesis was undertaken of material sourced from relevant journal publications, grey literature and policy documents.
RESULTS: Several models have proven accessible and acceptable forms of PHC to IDUs, improving the overall healthcare utilisation and health status of this population with consequent savings to the health system due to a reduction in visits to emergency departments and tertiary hospitals.
CONCLUSIONS: Although such findings are promising, there remains a dearth of rigorous evaluations of these targeted PHC, with the public health impact of such outlets yet to be systematically documented. Copyright Â
© 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21996165     DOI: 10.1016/j.drugpo.2011.08.005

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  30 in total

1.  Missed opportunities for hepatitis C testing and other opportunistic health care.

Authors:  M Mofizul Islam
Journal:  Am J Public Health       Date:  2013-10-17       Impact factor: 9.308

2.  A Hazard Analysis of Risk Factors of Mortality in Individuals Who Inject Drugs in Denver CO.

Authors:  Jonathan M Davis; Katie Suleta; Karen F Corsi; Robert E Booth
Journal:  AIDS Behav       Date:  2017-04

3.  Reductions in emergency department presentations associated with opioid agonist treatment vary by geographic location: A retrospective study in New South Wales, Australia.

Authors:  Nicola R Jones; Marian Shanahan; Timothy Dobbins; Louisa Degenhardt; Mark Montebello; Natasa Gisev; Sarah Larney
Journal:  Drug Alcohol Rev       Date:  2019-09

4.  Applying principles of injury and infectious disease control to the opioid mortality epidemic in North America: critical intervention gaps.

Authors:  Benedikt Fischer; Michelle Pang; Mark Tyndall
Journal:  J Public Health (Oxf)       Date:  2020-11-23       Impact factor: 2.341

Review 5.  Integrated opioid substitution therapy and HIV care: a qualitative systematic review and synthesis of client and provider experiences.

Authors:  Andy Guise; Maureen Seguin; Gitau Mburu; Susie McLean; Pippa Grenfell; Zahed Islam; Sergii Filippovych; Happy Assan; Andrea Low; Peter Vickerman; Tim Rhodes
Journal:  AIDS Care       Date:  2017-03-10

6.  Integrating health and prevention services in syringe access programs: a strategy to address unmet needs in a high-risk population.

Authors:  Carolyn K Burr; Deborah S Storm; Mary Jo Hoyt; Loretta Dutton; Linda Berezny; Virginia Allread; Sindy Paul
Journal:  Public Health Rep       Date:  2014 Jan-Feb       Impact factor: 2.792

7.  Associating conditional cash transfer to universal access to treatment could be the solution to the HCV epidemic among drug users (DUs).

Authors:  Philippe Chossegros; Fiorant Di Nino
Journal:  Harm Reduct J       Date:  2018-12-12

8.  Non-disclosure of drug use in outpatient health care settings: Findings from a prospective cohort study in Vancouver, Canada.

Authors:  Lindsay A Pearce; Fahmida Homayra; Laura M Dale; Soroush Moallef; Brittany Barker; Alexa Norton; Kanna Hayashi; Bohdan Nosyk
Journal:  Int J Drug Policy       Date:  2020-07-27

9.  Individual, social, and structural factors affecting antiretroviral therapy adherence among HIV-positive people who inject drugs in Kazakhstan.

Authors:  Alissa Davis; Tara McCrimmon; Anindita Dasgupta; Louisa Gilbert; Assel Terlikbayeva; Timothy Hunt; Sholpan Primbetova; Elwin Wu; Meruyert Darisheva; Nabila El-Bassel
Journal:  Int J Drug Policy       Date:  2018-10-22

10.  Wounds on wheels: implementing a specialized wound clinic within an established syringe exchange program in Baltimore, Maryland.

Authors:  Natanya Robinowitz; Maria Elisa Smith; Chris Serio-Chapman; Patrick Chaulk; Kristine E Johnson
Journal:  Am J Public Health       Date:  2014-09-11       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.